The ARCHITECT AUSAB assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of antibody to hepatitis B surface antigen (anti-HBs) in human adult and pediatric serum and plasma (dipotassium EDTA, lithium heparin, and sodium heparin) and neonatal serum
It is intended for quantitative measurement of antibody response following hepatitis B virus (HBV) vaccination, determination of HBV immune status, and for the laboratory diagnosis of HBV disease associated with HBV infection when used in conjunction with other laboratory results and clinical information
| Units of Measurement | |
|---|---|
| Manufacturer | ABBOTT DIAGNOSTI |
| UNSPSC | 41116004 |
| Product Specification Sheet | |
| SDS | SDS_ABBDIA_REAGENT_ARCHITECT_AUSAB_100_KT_D_S.pdf |
